Two spectroscopic methods for estimation of anti-migraine medications : Sumatriptan and Zolmitriptan based on nucleophilic substitution reaction
© 2022 John Wiley & Sons Ltd..
Sensitive and selective spectrophotometric and spectrofluorimetric methods have been developed for the estimation of two anti-migraine drugs, namely sumatriptan succinate (SUM) and zolmitriptan (ZOL). These methods depend on producing a yellow-coloured product after the reaction of the two drugs with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl). The reaction products exhibited maximum absorbance at 481 nm in borate buffer of pH 9 and fluorescence emission peak at 540 nm after excitation at 470 nm for the two drugs. The linear ranges were 5-60 μg/ml for SUM and 5-50 μg/ml for ZOL in the spectrophotometric method (Method I), whereas this was 0.4-4 μg/ml for SUM and 0.5-5 μg/ml for ZOL in the spectrofluorimetric method (Method II). The method validity was assessed according to International Council for Harmonisation (ICH) guidelines. Statistical analysis of the results obtained from the proposed and comparison methods confirmed that the proposed methods were highly accurate and precise. The suggested methods could be used for the determination of the mentioned drugs in both pure form and in tablets.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Luminescence : the journal of biological and chemical luminescence - 37(2022), 7 vom: 22. Juli, Seite 1174-1183 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abo El Abass, Samah [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2FS66TH3YW |
|---|
| Anmerkungen: |
Date Completed 06.07.2022 Date Revised 06.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/bio.4271 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340348801 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340348801 | ||
| 003 | DE-627 | ||
| 005 | 20231226004954.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/bio.4271 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1134.xml |
| 035 | |a (DE-627)NLM340348801 | ||
| 035 | |a (NLM)35506182 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abo El Abass, Samah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Two spectroscopic methods for estimation of anti-migraine medications |b Sumatriptan and Zolmitriptan based on nucleophilic substitution reaction |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.07.2022 | ||
| 500 | |a Date Revised 06.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 John Wiley & Sons Ltd. | ||
| 520 | |a Sensitive and selective spectrophotometric and spectrofluorimetric methods have been developed for the estimation of two anti-migraine drugs, namely sumatriptan succinate (SUM) and zolmitriptan (ZOL). These methods depend on producing a yellow-coloured product after the reaction of the two drugs with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl). The reaction products exhibited maximum absorbance at 481 nm in borate buffer of pH 9 and fluorescence emission peak at 540 nm after excitation at 470 nm for the two drugs. The linear ranges were 5-60 μg/ml for SUM and 5-50 μg/ml for ZOL in the spectrophotometric method (Method I), whereas this was 0.4-4 μg/ml for SUM and 0.5-5 μg/ml for ZOL in the spectrofluorimetric method (Method II). The method validity was assessed according to International Council for Harmonisation (ICH) guidelines. Statistical analysis of the results obtained from the proposed and comparison methods confirmed that the proposed methods were highly accurate and precise. The suggested methods could be used for the determination of the mentioned drugs in both pure form and in tablets | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a NBD-Cl | |
| 650 | 4 | |a Sumatriptan succinate | |
| 650 | 4 | |a Zolmitriptan | |
| 650 | 4 | |a spectrofluorimetric | |
| 650 | 4 | |a spectrophotometric | |
| 650 | 7 | |a Oxazolidinones |2 NLM | |
| 650 | 7 | |a Tablets |2 NLM | |
| 650 | 7 | |a Tryptamines |2 NLM | |
| 650 | 7 | |a zolmitriptan |2 NLM | |
| 650 | 7 | |a 2FS66TH3YW |2 NLM | |
| 650 | 7 | |a Sumatriptan |2 NLM | |
| 650 | 7 | |a 8R78F6L9VO |2 NLM | |
| 700 | 1 | |a Abo Zaid, Mona H |e verfasserin |4 aut | |
| 700 | 1 | |a El-Enany, Nahed |e verfasserin |4 aut | |
| 700 | 1 | |a Aly, Fatma |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Luminescence : the journal of biological and chemical luminescence |d 1999 |g 37(2022), 7 vom: 22. Juli, Seite 1174-1183 |w (DE-627)NLM103304983 |x 1522-7243 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2022 |g number:7 |g day:22 |g month:07 |g pages:1174-1183 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/bio.4271 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2022 |e 7 |b 22 |c 07 |h 1174-1183 | ||